1 – 10 of 10
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Immunizations With IFN gamma Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat Gliomas
(
- Contribution to journal › Article
-
Mark
Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
(
- Contribution to journal › Article
- 2007
-
Mark
Synergism between GM-CSF and IFNgamma: Enhanced immunotherapy in mice with glioma.
(
- Contribution to journal › Article
-
Mark
Inhibition of Inducible Nitric Oxide Synthase Enhances Anti-tumour Immune Responses in Rats Immunized with IFN-gamma-Secreting Glioma Cells.
(
- Contribution to journal › Article
-
Mark
Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors
(
- Contribution to journal › Article
- 2005
-
Mark
Immunization with autologous glioma cells transfected with IFN-g gene significantly prolongs survival in GBM-patients older than 50 years
2005) World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology In Neuro-Oncology 7(3). p.370-370(
- Contribution to journal › Published meeting abstract
-
Mark
Culturing of human tumor cells for use in immune gene tumor therapy
2005) World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology In Neuro-Oncology 7(3). p.371-371(
- Contribution to journal › Published meeting abstract
-
Mark
Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.
(
- Contribution to journal › Article
- 2004
-
Mark
Abstracts from the Ninth Annual Meeting of the Society for Neuro-Oncology
(
- Contribution to journal › Article
-
Mark
Identification and characterization of a human smad3 splicing variant lacking part of the linker region.
(
- Contribution to journal › Article